Cole Pinnow

Chief Commercial Officer, Cogent Biosciences, Inc.

Companies

Cogent Biosciences, Inc.Chief Commercial Officer May 29, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cogent Biosciences, Inc. COGT216,650 shares²$6.4M at $29.52Dec 17, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 17, 2025Shares withheld for tax 94,800 shares at $39.45 of Cogent Biosciences, Inc.²
Dec 17, 2025Granted 214,000 shares of Cogent Biosciences, Inc.²
Dec 17, 2025Granted 50,000 shares of Cogent Biosciences, Inc.²
Jan 14, 2025Bought 43,750 shares at $7.60 of Cogent Biosciences, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCogent Biosciences, Inc., Chief Commercial Officer
2
SEC EDGARCogent Biosciences, Inc. shares after the filing of Dec 17, 2025
3
SEC EDGARForm 4 filed Jan 15, 2025